Clinical Trial Update: EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing EDTA eye drops with Abreva for oral herpes eruptions has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Drugs mentioned

• ABREVA (Docosanol)
• EDTA Eye Drops (edetate disodium ophthalmic solution)

Snippet

Sponsor: University of Utah | Conditions: Herpes Simplex Oral | Phase 2 | Status: COMPLETED | Results posted: 2025-10-31